Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245349 · ClinicalTrials.gov registry record
Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 9
- Enrollment target
NCT00245349 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 9 participants.
The verdict
NCT00245349 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Preliminary observations suggest positron emission tomography (PET) imaging with an F-18 labeled thymidine analog (FLT) can selectively identify proliferating and non-proliferating tissues, including tumors. FLT uptake in the tumor appears to reflect the level of cells undergoing DNA synthesis. This is clinically important because cell proliferation markers have significant prognostic value, both prior to initiating radiotherapy and as they change during the course of therapy. In the proposed study, the researchers assess the biodistribution and radiation dosimetry of FLT to obtain the necessary data to file an Investigational New Drug (IND) application with the Food and Drug Administration (FDA). The information collected under Radioactive Drug Research Committee (RDRC) approval will not be used for diagnostic purposes, to assess the subject's response to therapy, or for clinical management of the subject.
Interventions
- PROCEDURE F-18 Fluorothymidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00245349
The ClinicalTrials.gov registry entry for NCT00245349 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which F-18 Fluorothymidine is the first listed.
NCT00245349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00245349 about?
NCT00245349 is a clinical study titled "Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer". Preliminary observations suggest positron emission tomography (PET) imaging with an F-18 labeled thymidine analog (FLT) can selectively identify proliferating and non-proliferating tissues, including tumors. FLT uptake in the tumor appears to reflect the level of cells undergoing DNA synthesis. This...
What is the current status of trial NCT00245349?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2005-10. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00245349?
The interventions under investigation include: F-18 Fluorothymidine (PROCEDURE).
Who is sponsoring clinical trial NCT00245349?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.